Barkley PMHNP Chapter Quiz 14: Stress,
Anxiety, and Somatic Disorders —
Advanced Clinical Examination (Version
2.0) a well detailed one
written and graded A+ upgraded
Title: Advanced Psychopharmacological and Psychotherapeutic Management of Stress-Triggered
Disorders: Integrating Neurobiological Mechanisms, Evidence-Based Treatment Algorithms, and
Differential Diagnostic Challenges in Anxiety and Somatic Symptom Disorders for PMHNP
Certification Preparation
Difficulty Level: Advanced / Mixed
Target Audience: PMHNP students, certification candidates, and practicing clinicians
Number of Questions: 150 multiple-choice questions with answers and rationales
SECTION A: NEUROENDOCRINE AND NEUROTRANSMITTER SYSTEMS (Questions 1–30)
1. The hypothalamic-pituitary-adrenal (HPA) axis negative feedback loop primarily involves
which of the following mechanisms?
,A) Cortisol binding to mineralocorticoid receptors in the amygdala
B) Cortisol binding to glucocorticoid receptors in the hippocampus and hypothalamus
C) ACTH binding to receptors in the adrenal medulla
D) CRH binding to receptors in the anterior pituitary
Correct Answer: B
Rationale: The HPA axis negative feedback loop involves cortisol binding to glucocorticoid
receptors in the hippocampus and hypothalamus, which inhibits further release of CRH and
ACTH. This is a critical regulatory mechanism that prevents excessive cortisol release.
2. Which of the following best describes the role of corticotropin-releasing hormone (CRH) in
anxiety disorders?
A) CRH is decreased in patients with anxiety disorders
B) CRH is increased in the cerebrospinal fluid of patients with anxiety disorders
C) CRH has no role in anxiety disorders
D) CRH is only involved in physical stress responses
Correct Answer: B
Rationale: Elevated CRH levels have been found in the cerebrospinal fluid of patients with
anxiety disorders, particularly those with PTSD and major depressive disorder. CRH is a key
mediator of the stress response and is implicated in the pathophysiology of anxiety.
3. The amygdala's response to threat is modulated by which of the following prefrontal cortex
subregions?
A) Dorsolateral prefrontal cortex (DLPFC)
B) Ventromedial prefrontal cortex (vmPFC)
C) Orbitofrontal cortex (OFC)
D) Anterior cingulate cortex (ACC)
Correct Answer: B
Rationale: The ventromedial prefrontal cortex (vmPFC) provides inhibitory control over the
amygdala's threat response. Reduced vmPFC activity is associated with impaired fear extinction
and heightened amygdala reactivity in anxiety disorders.
4. The neuropeptide S system has been implicated in which of the following anxiety-related
processes?
,A) Fear extinction and anxiolytic effects
B) HPA axis activation
C) Norepinephrine release
D) Cortisol secretion
Correct Answer: A
Rationale: Neuropeptide S has been shown to promote fear extinction and exert anxiolytic
effects in animal models. It is a relatively recent discovery in the neurobiology of anxiety and
stress regulation.
5. Which of the following is the primary mechanism by which glucocorticoids exert their
effects on the brain during chronic stress?
A) Rapid, non-genomic effects through membrane receptors
B) Genomic effects through intracellular glucocorticoid receptors
C) Direct inhibition of neurotransmitter release
D) Activation of the sympathetic nervous system
Correct Answer: B
Rationale: Glucocorticoids exert their effects primarily through genomic mechanisms, involving
binding to intracellular glucocorticoid receptors that translocate to the nucleus and modulate
gene expression. This is a slower process compared to non-genomic effects.
6. The orexin (hypocretin) system is involved in which of the following functions relevant to
anxiety?
A) Sleep-wake regulation and arousal
B) Memory consolidation
C) Motor coordination
D) Visual processing
Correct Answer: A
Rationale: The orexin system is primarily involved in sleep-wake regulation, arousal, and
reward. Dysregulation of the orexin system has been implicated in anxiety disorders, particularly
in relation to hyperarousal and sleep disturbances.
7. Which of the following is true regarding the role of the endocannabinoid system in stress
regulation?
, A) Endocannabinoids are stored in synaptic vesicles
B) Endocannabinoids are synthesized on-demand and act as retrograde messengers
C) Endocannabinoids have no role in fear extinction
D) CB1 receptors are only found in the peripheral nervous system
Correct Answer: B
Rationale: Endocannabinoids are synthesized on-demand from membrane phospholipids and
act as retrograde messengers, modulating neurotransmitter release. They play a critical role in
stress regulation and fear extinction.
8. The bed nucleus of the stria terminalis (BNST) is more involved in which type of anxiety
compared to the amygdala?
A) Phasic fear responses to immediate threats
B) Sustained, anticipatory anxiety
C) Social anxiety
D) Panic attacks
Correct Answer: B
Rationale: The BNST is more involved in sustained, anticipatory anxiety (e.g., chronic worry and
vigilance), whereas the amygdala is more involved in phasic fear responses to immediate
threats.
9. Which of the following neurotransmitter systems is the primary target of pregabalin's
mechanism of action?
A) GABA-A receptors
B) Voltage-gated calcium channels (alpha-2-delta subunit)
C) Serotonin transporters
D) Norepinephrine transporters
Correct Answer: B
Rationale: Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels,
reducing the release of excitatory neurotransmitters such as glutamate and norepinephrine.
This mechanism contributes to its anxiolytic effects.
10. The inflammatory hypothesis of anxiety suggests that:
Anxiety, and Somatic Disorders —
Advanced Clinical Examination (Version
2.0) a well detailed one
written and graded A+ upgraded
Title: Advanced Psychopharmacological and Psychotherapeutic Management of Stress-Triggered
Disorders: Integrating Neurobiological Mechanisms, Evidence-Based Treatment Algorithms, and
Differential Diagnostic Challenges in Anxiety and Somatic Symptom Disorders for PMHNP
Certification Preparation
Difficulty Level: Advanced / Mixed
Target Audience: PMHNP students, certification candidates, and practicing clinicians
Number of Questions: 150 multiple-choice questions with answers and rationales
SECTION A: NEUROENDOCRINE AND NEUROTRANSMITTER SYSTEMS (Questions 1–30)
1. The hypothalamic-pituitary-adrenal (HPA) axis negative feedback loop primarily involves
which of the following mechanisms?
,A) Cortisol binding to mineralocorticoid receptors in the amygdala
B) Cortisol binding to glucocorticoid receptors in the hippocampus and hypothalamus
C) ACTH binding to receptors in the adrenal medulla
D) CRH binding to receptors in the anterior pituitary
Correct Answer: B
Rationale: The HPA axis negative feedback loop involves cortisol binding to glucocorticoid
receptors in the hippocampus and hypothalamus, which inhibits further release of CRH and
ACTH. This is a critical regulatory mechanism that prevents excessive cortisol release.
2. Which of the following best describes the role of corticotropin-releasing hormone (CRH) in
anxiety disorders?
A) CRH is decreased in patients with anxiety disorders
B) CRH is increased in the cerebrospinal fluid of patients with anxiety disorders
C) CRH has no role in anxiety disorders
D) CRH is only involved in physical stress responses
Correct Answer: B
Rationale: Elevated CRH levels have been found in the cerebrospinal fluid of patients with
anxiety disorders, particularly those with PTSD and major depressive disorder. CRH is a key
mediator of the stress response and is implicated in the pathophysiology of anxiety.
3. The amygdala's response to threat is modulated by which of the following prefrontal cortex
subregions?
A) Dorsolateral prefrontal cortex (DLPFC)
B) Ventromedial prefrontal cortex (vmPFC)
C) Orbitofrontal cortex (OFC)
D) Anterior cingulate cortex (ACC)
Correct Answer: B
Rationale: The ventromedial prefrontal cortex (vmPFC) provides inhibitory control over the
amygdala's threat response. Reduced vmPFC activity is associated with impaired fear extinction
and heightened amygdala reactivity in anxiety disorders.
4. The neuropeptide S system has been implicated in which of the following anxiety-related
processes?
,A) Fear extinction and anxiolytic effects
B) HPA axis activation
C) Norepinephrine release
D) Cortisol secretion
Correct Answer: A
Rationale: Neuropeptide S has been shown to promote fear extinction and exert anxiolytic
effects in animal models. It is a relatively recent discovery in the neurobiology of anxiety and
stress regulation.
5. Which of the following is the primary mechanism by which glucocorticoids exert their
effects on the brain during chronic stress?
A) Rapid, non-genomic effects through membrane receptors
B) Genomic effects through intracellular glucocorticoid receptors
C) Direct inhibition of neurotransmitter release
D) Activation of the sympathetic nervous system
Correct Answer: B
Rationale: Glucocorticoids exert their effects primarily through genomic mechanisms, involving
binding to intracellular glucocorticoid receptors that translocate to the nucleus and modulate
gene expression. This is a slower process compared to non-genomic effects.
6. The orexin (hypocretin) system is involved in which of the following functions relevant to
anxiety?
A) Sleep-wake regulation and arousal
B) Memory consolidation
C) Motor coordination
D) Visual processing
Correct Answer: A
Rationale: The orexin system is primarily involved in sleep-wake regulation, arousal, and
reward. Dysregulation of the orexin system has been implicated in anxiety disorders, particularly
in relation to hyperarousal and sleep disturbances.
7. Which of the following is true regarding the role of the endocannabinoid system in stress
regulation?
, A) Endocannabinoids are stored in synaptic vesicles
B) Endocannabinoids are synthesized on-demand and act as retrograde messengers
C) Endocannabinoids have no role in fear extinction
D) CB1 receptors are only found in the peripheral nervous system
Correct Answer: B
Rationale: Endocannabinoids are synthesized on-demand from membrane phospholipids and
act as retrograde messengers, modulating neurotransmitter release. They play a critical role in
stress regulation and fear extinction.
8. The bed nucleus of the stria terminalis (BNST) is more involved in which type of anxiety
compared to the amygdala?
A) Phasic fear responses to immediate threats
B) Sustained, anticipatory anxiety
C) Social anxiety
D) Panic attacks
Correct Answer: B
Rationale: The BNST is more involved in sustained, anticipatory anxiety (e.g., chronic worry and
vigilance), whereas the amygdala is more involved in phasic fear responses to immediate
threats.
9. Which of the following neurotransmitter systems is the primary target of pregabalin's
mechanism of action?
A) GABA-A receptors
B) Voltage-gated calcium channels (alpha-2-delta subunit)
C) Serotonin transporters
D) Norepinephrine transporters
Correct Answer: B
Rationale: Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels,
reducing the release of excitatory neurotransmitters such as glutamate and norepinephrine.
This mechanism contributes to its anxiolytic effects.
10. The inflammatory hypothesis of anxiety suggests that:
